Sign in
Stories
Uber to Biotech Success Story
Share
ARQIS Advises on Candy Kittens Investmen...
Anillo Industries Acquired by Novaria Gr...
Antler Fuels Innovation in UK Tech
AB Akola Group Backs Brite's Expansion
Afya Limited Expands Medical Seats in Br...
Alantra Advises Nimble Approach on SCC I...
Overview
API
Joshua Britton, a Ph.D. in biochemistry, turned an Uber ride into a $100k investment that seeded his biotech company, Debut. Debut secured substantial funding rounds and launched Deinde skincare brand, planning to innovate the fragrance sector with bioreactor technology.
Ask a question
How does Debut's bioreactor technology mimic nature in revolutionizing the fragrance industry?
How might Debut's success impact the interest of investors in funding similar biotech startups?
What potential challenges might Debut face in scaling its biotechnology innovations globally?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Jan 2024
Feb 2024
Mar 2024
Coverage